Owing to its functional overlap with ATM, a DDR kinase already implicated in BC susceptibility, ATR has been previously tested as a potential candidate gene in two breast and ovarian cancer cohorts of respectively 126 and 54 patients without alterations of BRCA1/2. The gene discussed is ATR; the disease is ovarian carcinoma.